Thomas Lewis, author of “The End of Alzheimer’s: A Differential Diagnosis Toward a Cure,” is a microbiologist with a Ph.D. from MIT. He’s done a lot of work on diagnostic testing, and in this interview, we explore how retinal assessment and other laboratory tests can be used to stratify your risk factors for chronic disease and COVID-19. Lewis recently published an excellent paper on this.